Isoray, Inc. Announces Pricing of $9.5 Million Public Offering
Oppenheimer & Co. Inc. is acting as the sole book-running manager for the offering.
- Home
- About
- Brachytherapy
Patient Information
Clinician Information
Cesium 131 Products
- Theranostics
- Newsroom
- Investor Center
- Contact us
